ArticleScientific reports2025
Midterm cardiovascular outcomes in children with MIS-C compared to Kawasaki disease: a multicenter prospective cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cardiovascular Sequelae After SARS-CoV-2 in Children: From Myocardial Injury to Dysautonomia and Implications for Phenotype-Guided Follow-Up.Pediatric cardiology · 2026Review
- Long-Term Evolution of Myocardial Strain and Coronary Artery Z-Scores in Multisystem Inflammatory Syndrome in ChildrenChildren (Basel, Switzerland) · 2026Review
- Research Progress on Coronary Artery Injury and Myocardial Ischemia in Multisystem Inflammatory Syndrome in Children.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The overlapping features of multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease (KD) raise concerns regarding midterm cardiovascular sequelae. We conducted a multicenter prospective cohort study to compare midterm outcomes in MIS-C and KD survivors. A total of 122 children (MIS-C, n = 66; KD, n = 56) underwent echocardiographic follow-up 1-3 years post-diagnosis. Outcomes included left ventricular ejection fraction (LVEF), coronary abnormalities, and left ventricular global longitudinal strain (LVGLS). Notably, the median age at diagnosis was higher in MIS-C (5.7 years, IQR 3.0-9.4) than in KD (1.5 years, IQR 1.1-2.8) (P < 0.01). Initial left ventricular dysfunction occurred more frequently in MIS-C (25.8%) than KD (0%) (P < 0.01). By the median follow-up of 1.5 years (IQR 1.1-1.9), all patients who had previously been diagnosed with left ventricular dysfunction had recovered to normal LVEF in both groups. However, one MIS-C patient had persistently abnormal LVGLS, suggesting subclinical impairment. Coronary abnormalities in MIS-C decreased from 30% at baseline to 1.5% at follow-up. In contrast, persistent coronary abnormalities remained in KD, despite preserved cardiac function and LVGLS. At follow-up, coronary abnormalities including coronary ectasia and aneurysm were significantly higher in KD (14.2%) compared with MIS-C (1.5%) (P < 0.01). In conclusion, MIS-C was associated with transient ventricular dysfunction but rare persistent coronary involvement, whereas KD carried a higher burden of midterm coronary abnormalities. Clinical trial registration: TCTR20230414003.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.